Literature DB >> 29890316

Effects of a homogeneous polysaccharide from Sijunzi decoction on human intestinal microbes and short chain fatty acids in vitro.

Beibei Gao1, Ruijun Wang1, Ying Peng1, Xiaobo Li2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Sijunzi decoction (SJZD) is a classic recipe in traditional Chinese medicine (TCM) to strengthen the spleen and replenish Qi. It is well known for treating disorders of gastrointestinal function manifested in poor appetite, reduced food intake and loose stools. Polysaccharide is the most abundant constituent and the major effective component in SJZD. AIM OF THE STUDY: The present study aimed to understand the immunomodulatory mechanism of S-3-1, a homogeneous polysaccharide purified from SJZD with immune-enhancement activity, by investigating its effects on human intestinal microbes and short chain fatty acids.
MATERIALS AND METHODS: S-3-1 was incubated with simulated gastric juice, intestinal juice, and human fecal microflora independently and sequentially. The concentrations of total polysaccharide and reducing sugar were measured to identify the stability of independently and sequentially incubated S-3-1 in three in vitro fermentation models. Gas chromatograph (GC) analysis was used to measure the short chain fatty acid (SCFA) contents in human fecal samples. The human gut microbiota composition was measured by 16S rRNA gene Illumina MiSeq sequencing (V3-V4 region).
RESULTS: S-3-1 was degraded in three in vitro fermentation models separately and sequentially. Both S-3-1 and incubated S-3-1 could regulate the abundances of Lactobacillus, Pediococcus, Streptococcus, Bacteroides, Enterococcus, Clostridium and Dorea in human intestinal microflora samples. Specifically, S-3-1 could only regulate the abundances of Paraprevotella and Oscillospira, while the influenced flora changed to Butyricimonas, Coprococcus, Dialister, Sutterella, Ruminococcus and Parabacteroides after sequential incubation of S-3-1. In contrast to S-3-1 showing no influence on the content of SCFA, incubated S-3-1 showed increased contents of acetic acid and total acid that were associated with its effects on the abundances of Enterococcus, Sutterella, Butyricimonas and Streptococcus.
CONCLUSION: S-3-1 plays an immunomodulatory role by regulating the abundances of 9 intestinal bacteria genera. Incubated S-3-1 can regulate more bacteria genera, a total of 13 kinds, and can adjust the SCFA content to affect immunomodulation. Incubation with gastric and intestinal juices enhanced S-3-1's capability of modulating the intestinal flora composition and decreased the bacteria's need for a carbon source. This study could provide new insights for studies on the pharmacological mechanisms of polysaccharides in vitro.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gut microbiota; Homogeneous polysaccharide; Illumina 16s rRNA gene sequencing; Short chain fatty acids; Sijunzi decoction

Mesh:

Substances:

Year:  2018        PMID: 29890316     DOI: 10.1016/j.jep.2018.06.006

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

Review 1.  Molecular Mechanism of Polysaccharides Extracted from Chinese Medicine Targeting Gut Microbiota for Promoting Health.

Authors:  Wen-Xiao Zhao; Tong Wang; Ya-Nan Zhang; Qian Chen; Yuan Wang; Yan-Qing Xing; Jun Zheng; Chen-Chen Duan; Li-Jun Chen; Hai-Jun Zhao; Shi-Jun Wang
Journal:  Chin J Integr Med       Date:  2022-05-18       Impact factor: 1.978

2.  Gut Microbial Signatures Associated with Peanut Allergy in a BALB/c Mouse Model.

Authors:  Shimin Gu; Qiang Xie; Chen Chen; Chenglong Liu; Wentong Xue
Journal:  Foods       Date:  2022-05-12

Review 3.  Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.

Authors:  Wuwen Feng; Hui Ao; Cheng Peng
Journal:  Front Pharmacol       Date:  2018-11-23       Impact factor: 5.810

4.  Comparison of the Modulatory Effect on Intestinal Microbiota between Raw and Bran-Fried Atractylodis Rhizoma in the Rat Model of Spleen-Deficiency Syndrome.

Authors:  Shanpeng Ma; Yujun Jiang; Beixue Zhang; Jian Pang; Xiaoying Xu; Jianzhi Sun; Xin Lv; Qian Cai
Journal:  Int J Environ Res Public Health       Date:  2019-08-31       Impact factor: 3.390

5.  Egg oil from Portunus trituberculatus alleviated obesity and regulated gut microbiota in mice.

Authors:  Shiwei Hu; Huicheng Yang; Xiang Gao; Shijie Li; Wei Jiang; Yu Liu
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

6.  Xylooligosaccharide Modulates Gut Microbiota and Alleviates Colonic Inflammation Caused by High Fat Diet Induced Obesity.

Authors:  Yanquan Fei; Yan Wang; Yilin Pang; Wenyan Wang; Dan Zhu; Meigui Xie; Shile Lan; Zheng Wang
Journal:  Front Physiol       Date:  2020-01-22       Impact factor: 4.566

Review 7.  Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine.

Authors:  Tingshuai Wang; Shaodong Huang; Cong Wu; Na Wang; Rongzhen Zhang; Minggang Wang; Dewen Mao
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-22       Impact factor: 2.629

8.  An integrated strategy of MS-network-based offline 2DLC-QTOF-MS/MS coupled with UHPLC-QTRAP®-MS/MS for the characterization and quantification of the non-polysaccharides in Sijunzi decoction.

Authors:  Bangjian Dong; Chongsheng Peng; Ping Ma; Xiaobo Li
Journal:  Anal Bioanal Chem       Date:  2021-04-13       Impact factor: 4.142

9.  Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology.

Authors:  Wuwen Feng; Juan Liu; Dandan Zhang; Yuzhu Tan; Hao Cheng; Cheng Peng
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

10.  Quxie Capsule Modulating Gut Microbiome and Its Association With T cell Regulation in Patients With Metastatic Colorectal Cancer: Result From a Randomized Controlled Clinical Trial.

Authors:  Lingyun Sun; Yunzi Yan; Dongmei Chen; Yufei Yang
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.